Predictors and Outcomes of In-hospital HFpEF in AMI Patients
- Conditions
- Acute Myocardial InfarctionPredictorPrognosisHeart Failure With Preserved Ejection Fraction
- Registration Number
- NCT03351179
- Lead Sponsor
- Xiangjun Yang
- Brief Summary
This retrospective observation is to investigate the incidence,clinical outcomes and prognosis of hospitalized heart failure with preserved ejection fraction (HFpEF) in patients with acute myocardial infarction(AMI).
- Detailed Description
1. Patients with first AMI undergoing primary percutaneous coronary intervention (PCI) in our hospital since January 2013 were retrospectively evaluated. The enrolled subjects were divided into two groups (AMI patients with HFpEF and AMI patients without HF).
2. The investigator collected the clinical data of participants' demographics (age, sex), previous history,risk factors for AMI (hypertension, hyperlipidemia, diabetes mellitus, smoking and stroke), laboratory biomarkers, echocardiographic measurements, clinical characteristics,medical procedures and treatments, as well as in-hospital complications.
3. Two sub-investigators independently analyzed these data by using SPSS software.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 500
- First AMI patients undergoing PCI with HFpEF or without HF.
- First AMI patients with heart failure with reduced ejection fraction.
- First AMI patients with severe inflammatory diseases, valvular heart disease, non-cardiac caused symptoms, serious hepatic and renal failure, congenital cardiomyopathy,or pericardial diseases.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Risk factors of incident in-hospital HFpEF Outcome measure will be assessed at discharge, and data will be reported through study completion, an average of 1 year.
- Secondary Outcome Measures
Name Time Method Clinical prognosis in patients with HFpEF Outcome measure will be assessed at discharge, and data will be reported through study completion, an average of 1 year.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
the First Affiliated Hospital of Soochow University
🇨🇳Suzhou, Jiangsu, China
the First Affiliated Hospital of Soochow University🇨🇳Suzhou, Jiangsu, China